Story perspectives

Bipartisan Lawmakers Introduce Act to Combat Drug Shortages

1/24/2025

28 6

Summary

Story summary

A bipartisan coalition of U.S. lawmakers has unveiled the End Drug Shortages Act, designed to enhance communication among drug manufacturers, the FDA, and pharmacies to tackle the growing issue of drug shortages. In parallel, the FDA is weighing restrictions on compounded GLP-1 medications, driven by safety concerns raised by Novo Nordisk. Meanwhile, HHS is cracking down on healthcare providers who block information, aiming to improve patient care.

1 of 1

Story summary

A bipartisan coalition of U.S. lawmakers has unveiled the End Drug Shortages Act, designed to enhance communication among drug manufacturers, the FDA, and pharmacies to tackle the growing issue of drug shortages. In parallel, the FDA is weighing restrictions on compounded GLP-1 medications, driven by safety concerns raised by Novo Nordisk. Meanwhile, HHS is cracking down on healthcare providers who block information, aiming to improve patient care.